0.58% -0.84

Dopo l'orario di chiusura: 143.39 -1.42 -0.98%

Gilead Sciences Inc (GILD)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché GILD Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Gilead Sciences Inc (GILD)

Gilead Sciences Inc Borsa (GILD) Ultime notizie

If You Invested $100 In Gilead Sciences Stock 20 Years Ago, You Would Have This Much Today - Benzinga

GILD Maintained by HSBC -- Price Target Raised to $175 - GuruFocus

Gilead Sciences Sees Sunlenca Launch Fueling Long-Term HIV Growth - MarketBeat

Gilead Sciences at 12th Annual Cantor Fitzgerald Global Healthcare Conference: broader growth - Investing.com UK

GSK's Specialty Medicines Drive Growth Amid Looming HIV Patent Cliff - Zacks Investment Research

In draft guidance, NICE rebuffs Gilead's twice-a-year PrEP med for national coverage - Fierce Pharma

HSBC Issues Positive Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price - MarketBeat

Tidal Investments LLC Raises Position in Gilead Sciences, Inc. $GILD - MarketBeat

Gilead Sciences, Inc. $GILD Shares Acquired by National Pension Service - MarketBeat

NICE says no to Gilead's lenacapavir for HIV PrEP - pharmaphorum

Gilead Sciences stock holds near highs as Q2 2026 EPS beats and new ex-dividend date nears - ad-hoc-news.de

Engineers Gate Manager LP Acquires Shares of 112,886 Gilead Sciences, Inc. $GILD - MarketBeat

Allworth Financial LP Sells 8,687 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Gilead Sciences stock heads into the open after a 0.7 percent dip - ad-hoc-news.de

Gilead Sciences Eyes HIV, Oncology Catalysts as Pipeline Enters Execution Mode - Yahoo Finance

Gilead Sciences stock falls as investors reassess post-earnings rally - ad-hoc-news.de

Gilead launches research facility in US for new medicine development - Yahoo Finance

NewEdge Advisors LLC Raises Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

How Bixlenvo Approval At Gilead Sciences (GILD) Has Changed Its Investment Story - simplywall.st

Gilead opens new building on existing Foster City campus - NBC Bay Area

Gilead National Ribbon Cutting Ceremony - Post Register

Gilead Sciences (GILD) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance

Assembly Bio stock gains after exercising Gilead profit option By Investing.com - Investing.com South Africa

Assembly Bio stock gains after exercising Gilead profit option - Investing.com India

Gilead Sciences Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program - The Manila Times

A $75 million Gilead payment is due in Q4, while Assembly Bio expects cash to fund operations into 2029. - Stock Titan

Gilead Opens 182,000-Square-Foot Research Center in Foster City - Contract Pharma

Gilead Sciences Inc Stock (GILD) Moved Down by 3.26% on Sep 8: Drivers Behind the Movement - TradingKey

Gilead Opens State-of-the-Art Research Center to Advance the Next Generation of Medicines - Gilead Sciences

Gilead Sciences stock gains on fresh analyst buy rating and Q2 loss swing - AD HOC NEWS

Gilead Sciences Slides 3.4% as Investors Digest Prior Gains and Ongoing Pricing Risks - Moomoo

Gilead opens research center as $32 billion US build-out continues - The Pharma Letter

Gilead Sciences, Inc. $GILD Shares Purchased by Groupe la Francaise - MarketBeat

California State Teachers Retirement System Has $30.47 Billion Stake in Gilead Sciences, Inc. $GILD - MarketBeat

Bixlenvo Gives Gilead a New HIV Growth Path. How Large is the Market? - Yahoo Finance

[Press release] FDA approves Gilead’s Bixlenvo™, a new once-daily single tablet option for virologically suppressed adults with HIV, including those on complex regimens - European AIDS Treatment Group

Gilead Sciences stock gains after narrowing Q2 loss and firming 2026 guidance - AD HOC NEWS

Gilead Sciences, Inc. $GILD Holdings Raised by HighTower Advisors LLC - MarketBeat

VIRGINIA RETIREMENT SYSTEMS ET Al Takes $130.42 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat

Gilead Sciences, Inc. (GILD) Stock Analysis: Evaluating the Prospects with a 4.25% Potential Upside - DirectorsTalk Interviews

Could Gilead Sciences (NASDAQ:GILD) Remain a Nasdaq Focus? - Kalkine Media

Amundi Has $1.23 Billion Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

Saudi Central Bank Acquires 41,091 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Gilead Sciences Strategically Prepares for HIV Market Changes - Intellectia AI

Gilead Sciences Just Won Its Third FDA Approval in Less Than 4 Months. Is the Stock Still Underrating This Turnaround Play? - Yahoo Finance

Gilead Sciences (NASDAQ:GILD) Lowered to Hold Rating by Wall Street Zen - MarketBeat

Will New HIV and Oncology Approvals Redefine Gilead Sciences' (GILD) Treatment Platform Narrative? - Yahoo Finance

Gilead Keeps Writing Bigger Checks—But Can the Drugs Keep Paying for Them? - AOL.com

Q&A: Gilead's Betty Chiang on what Bixlenvo means for HIV patients on complex regimens - The Pharma Letter

Gilead Sciences (NASDAQ:GILD): A Quality Dividend Stock for Income Investors - ChartMill

NEOS Investment Management LLC Has $120.08 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat

TD Waterhouse Canada Inc. Sells 70,572 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

AXQ Capital LP Makes New Investment in Gilead Sciences, Inc. $GILD - MarketBeat

Gilead Sciences Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch

Gilead Sciences (GILD) Chairman & CEO Daniel O'Day Sells 15,000 Shares - GuruFocus

Why Is Gilead (GILD) Up 13.6% Since Last Earnings Report? - finance.yahoo.com

Gilead Sciences Q1 EPS Estimate Raised by Zacks Research - MarketBeat

Is Gilead Sciences Stock Outperforming the S&P 500? - Barchart.com

Nykredit A S Makes New $177.13 Million Investment in Gilead Sciences, Inc. $GILD - MarketBeat

iSAM Funds UK Ltd Buys New Stake in Gilead Sciences, Inc. $GILD - MarketBeat

B. Metzler seel. Sohn & Co. AG Boosts Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

Gilead Sciences (NASDAQ:GILD) CEO Sells 15,000 Shares of Stock - MarketBeat

Gilead (NASDAQ: GILD) CEO sells 15,000 shares near $150 - Stock Titan

Gilead Sciences stock gains as analysts turn more positive - AD HOC NEWS

Gilead Sciences (NASDAQ:GILD) Raised to "Strong-Buy" at Zacks Research - MarketBeat

Zacks Research Lifts Earnings Estimates for Gilead Sciences - MarketBeat

Gilead Sciences Inc. stock outperforms competitors on strong trading day - MarketWatch

Can Bixlenvo Unlock New Growth for Gilead's HIV Business? - Yahoo Finance

Gilead Sciences stock holds near $146 after a revenue beat - AD HOC NEWS

Simile a GILD